Health & Medicine

Stanford's Evo 2 AI Designs Bacteriophages Capable of Destroying E. Coli Bacteria

Stanford researchers used the generative model Evo 2 to design nearly 300 DNA sequences, which were then turne…

Artificial Intelligence Accelerates Discovery of Next-Generation Biologic Drugs

Researchers are turning to artificial intelligence models to cut the cost and time required to develop biologi…

Anthropic launches Claude Science: artificial intelligence sets its sights on rewriting the rules of biomedical research in Kendall Square

Anthropic is expanding the ambitions of its artificial intelligence model beyond streamlining corporate proces…

Bristol Myers Squibb Acquires Nvidia Supercomputer to Accelerate Drug Discovery

Pharmaceutical company Bristol Myers Squibb will become the first life sciences firm to deploy an Nvidia DGX S…

Bristol Myers Squibb Unveils NVIDIA-Powered AI Supercomputer, Calls It "Largest in Pharma"

Bristol Myers Squibb has become the third pharmaceutical company in nine months to claim it is building the la…

Anthropic, the artificial intelligence giant, is entering the pharmaceutical industry and has announced that it will develop its own drugs

AI Competition for Drug Metabolism: Data Quality Beats Giant Models

The results of a recent AI competition focused on predicting drug candidate properties are overturning a widel…

Takeda Invests $600 Million in AI-Powered Drug Discovery Partnership with Insilico Medicine

Japanese pharmaceutical giant Takeda has signed a strategic agreement with Hong Kong-based Insilico Medicine t…

An AI-Discovered Drug Enters Phase III Clinical Trials for a Serious Lung Disease

Insilico Medicine has announced that a drug identified using artificial intelligence algorithms is advancing t…